Ophthotech Corp (OPHT) Misses Q2 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
UPDATE: Goldman Sachs Expects Underperformance at Ophthotech (OPHT), Cuts to Sell
August 7, 2015 7:02 AM EDT(Updated - August 7, 2015 9:40 AM EDT)
Goldman Sachs downgraded Ophthotech Corp (NASDAQ: OPHT) from Neutral to Sell with a price target of $45 (unchanged). Analyst Terence Flynn expects share price underperformance due to competitor updates, as well as lack of meaningful catalysts.
"One of the tenants to our thesis has been potential future competition... More



